recent contract with A2 and others plus the new ANN, it seems the big raise is just started. this one is going to draw more attention from the market.
today will see another nice run again. IMO.
Proteomics market forecast to be $20.8 billion by 2018, with key metrics including:
- Bio-engineered protein drugs was $152 billion (2013) CAGR 7.2%, and 7 of world's top 10 selling drugs were proteins
therapeutics;
- Between 2013 and 2017 drugs worth $50 billion per annum in revenues come off patent which is driving the generic
protein drug market to which PIQ provides testing services Biomarkers (new diagnostics) market is $17.5 billion and
predicted to reach $40.8 billion by 2018; and
- Proteomics and genomics technology holds ~75% share.
Diabetes currently affects 382 million people globally, and one of its major complications is diabetic kidney disease.
20% of adults with diabetes will end up with kidney failure.
PIQ Price at posting:
71.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)